On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Genibet - Biopharmaceuticals SA's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€2.3M · 4 projects
- Horizon Europe€1.6M · 2 projects
- Horizon 2020€1.2M · 4 projects
Projects
10 EU-funded projects, newest first. Each links to the official record.
- CAAREAssociated partner
Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy
Horizon Europe · 2024–2028 · Project on CORDIS ↗
- UltiMalVaxPartner
A Vaccine Targeting Eradication of Malaria
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€1.6Mtheir share - TRANSVAC-DSPartner
DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE
Horizon 2020 · 2020–2023 · Project on CORDIS ↗
€12ktheir share - CRUZIVAXPartner
Vaccine for prevention and treatment of Trypanosoma cruzi infection
Horizon 2020 · 2019–2025 · Project on CORDIS ↗
€861ktheir share - TRANSVAC2Partner
European Vaccine Research and Development Infrastructure
Horizon 2020 · 2017–2023 · Project on CORDIS ↗
€109ktheir share - DiViNePartner
Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes
Horizon 2020 · 2015–2020 · Project on CORDIS ↗
€250ktheir share - HepaMAbPartner
Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€1.5Mtheir share - BRAINVECTORSPartner
From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV""
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€104ktheir share - €469ktheir share
- BRAINCAVPartner
NONHUMAN ADENOVIRUS VECTORS FOR GENE TRANSFER TO THE BRAIN
FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗
€252ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Instituto de Biologia Experimental e TecnologicaPortugal · 8 shared projects
- Universidade Nova de LisboaPortugal · 4 shared projects
- Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 3 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 3 shared projects
- Helmholtz-Zentrum Fur Infektionsforschung GmbHGermany · 3 shared projects
- European Vaccine Initiative eVGermany · 3 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 2 shared projects
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 2 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 2 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- Institut National de Recherche Pour L'Agriculture, L'Alimentation et L'EnvironnementFrance · 2 shared projects
- Stichting Wageningen ResearchNetherlands · 2 shared projects
- Universita Degli Studi di Roma la SapienzaItaly · 2 shared projects
- Universitat Autonoma de BarcelonaSpain · 2 shared projects
- London School of Hygiene and Tropical Medicine Royal CharterUnited Kingdom · 2 shared projects
- Statens Serum InstitutDenmark · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- alkali metals
- bacteriology
- bioprocessing technologies
- catalysis
- cells technologies
- gene therapy
- hepatitis C
- hepatology
- immunology
- immunotherapy
- infectious diseases
- inflammatory bowel disease
- malaria
- mass spectrometry
Genibet - Biopharmaceuticals SA is listed on EUACC
See the startup profile for its product, team and what it is looking for.
Open the startup profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
